Stay updated with breaking news from Nasdaq Blte. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Belite Bio, Inc (NASDAQ:BLTE – Get Free Report) saw a large increase in short interest in the month of July. As of July 31st, there was short interest totalling 46,100 shares, an increase of 30.6% from the July 15th total of 35,300 shares. Based on an average trading volume of 56,500 shares, the short-interest ratio […]
HC Wainwright reiterated their buy rating on shares of Belite Bio (NASDAQ:BLTE – Free Report) in a research note published on Thursday, Benzinga reports. They currently have a $55.00 price target on the stock. A number of other research analysts have also commented on the stock. Leerink Partnrs restated an outperform rating on shares of […]
Belite Bio, Inc (NASDAQ:BLTE – Get Free Report) saw a significant growth in short interest in July. As of July 31st, there was short interest totalling 46,100 shares, a growth of 30.6% from the July 15th total of 35,300 shares. Based on an average daily trading volume, of 56,500 shares, the short-interest ratio is currently […]
Belite Bio (NASDAQ:BLTE – Get Free Report) issued its earnings results on Tuesday. The company reported ($0.26) EPS for the quarter, missing the consensus estimate of ($0.23) by ($0.03), MarketWatch Earnings reports. Belite Bio Price Performance Shares of BLTE stock traded up $1.44 during trading hours on Thursday, reaching $24.50. The company’s stock had a […]
Completed enrollment in pivotal Phase 3 “DRAGON” trial for Tinlarebant in adolescent Stargardt disease (“STGD1”) with 100 subjects enrolled across 11...